EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 32 (2025) Parasite, 32 (2025) 26 References
Open Access
Issue
Parasite
Volume 32, 2025
Article Number 26
Number of page(s) 12
DOI https://doi.org/10.1051/parasite/2025018
Published online 16 April 2025
  1. Abou Rayia DM, Izzularab BM, Harras S, Ghafar MTA, Azzam AR, Harras H, Younis RL, Soliman S, Saad AE. 2023. Stem cell biotherapy: a new remedy for Trichinella spiralis-induced inflammatory myopathy. Parasitology International 96, 102773. [CrossRef] [PubMed] [Google Scholar]
  2. Alameddine J, Godefroy E, Papargyris L, Sarrabayrouse G, Tabiasco J, Bridonneau C, Yazdanbakhsh K, Sokol H, Altare F, Jotereau F. 2019. Faecalibacterium prausnitzii skews Human DC to prime IL10-producing T cells through TLR2/6/JNK signaling and IL-10, IL-27, CD39, and IDO-1 induction. Frontiers in Immunology. 10, 143. [CrossRef] [Google Scholar]
  3. Ashour DS. 2013. Trichinella spiralis immunomodulation: an interactive multifactorial process. Expert Review of Clinical Immunology 9(7), 669–675. [CrossRef] [PubMed] [Google Scholar]
  4. Bai X, Wu X, Wang X, Guan Z, Gao F, Yu J, Yu L, Tang B, Liu X, Song Y, Wang X, Radu B, Boireau P, Wang F, Liu M. 2011. Regulation of cytokine expression in murine macrophages stimulated by excretory/secretory products from Trichinella spiralis in vitro. Molecular and Cellular Biochemistry 360(1–2), 79–88. [Google Scholar]
  5. von Bubnoff D, Scheler M, Wilms H, Wenzel J, von Bubnoff N, Häcker G, Schultze J, Popov A, Racz P, Bieber T, Wickenhauser C. 2011. Indoleamine 2, 3-dioxygenase-expressing myeloid dendritic cells and macrophages in infectious and noninfectious cutaneous granulomas. Journal of the American Academy of Dermatology, 65(4), 819–832. [CrossRef] [PubMed] [Google Scholar]
  6. Catani L, Sollazzo D, Trabanelli S, Curti A, Evangelisti C, Polverelli N, Palandri F, Baccarani M, Vianelli N, Lemoli RM. 2012. Decreased expression of indoleamine 2, 3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia. Annals of Hematology 92(1), 67–78. [Google Scholar]
  7. Chen D, Koropatnick J, Jiang N, Zheng X, Zhang X, Wang H, Yuan K, Siu KS, Shunnar A, Way C, Min WP. 2014. Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma. Journal of Immunotherapy, 37(2), 123–134. [CrossRef] [PubMed] [Google Scholar]
  8. Chen J, Li J, Qiao H, Hu R, Li C. 2023. Disruption of IDO signaling pathway alleviates chronic unpredictable mild stress-induced depression-like behaviors and tumor progression in mice with breast cancer. Cytokine, 162, 156115. [CrossRef] [PubMed] [Google Scholar]
  9. Ebrahimi A, Kardar GA, Teimoori-Toolabi L, Ghanbari H, Sadroddiny E. 2016. Inducible expression of indoleamine 2, 3-dioxygenase attenuates acute rejection of tissue-engineered lung allografts in rats. Gene, 576(1), 412–420. [CrossRef] [PubMed] [Google Scholar]
  10. Flatekval GF, Sioud M. 2009. Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase, Immunology, 128, e837–e848. [CrossRef] [PubMed] [Google Scholar]
  11. Grohmann U. 2003. Tolerance, DCs and tryptophan: much ado about IDO. Trends in Immunology, 24(5), 242–248. [CrossRef] [PubMed] [Google Scholar]
  12. Gruden-Movsesijan A, Ilic N, Colic M, Majstorovic I, Vasilev S, Radovic I, Sofronic-Milosavljevic LJ. 2011. The impact of Trichinella spiralis excretory–secretory products on dendritic cells. Comparative Immunology, Microbiology and Infectious Diseases, 34(5), 429–439. [CrossRef] [PubMed] [Google Scholar]
  13. Huang Y-S, Ogbechi J, Clanchy FI, Williams RO, Stone TW. 2020. IDO and kynurenine metabolites in peripheral and CNS disorders. Frontiers in Immunology, 11, 388. [CrossRef] [PubMed] [Google Scholar]
  14. Ilic N, Gruden-Movsesijan A, Sofronic-Milosavljevic L. 2012. Trichinella spiralis: shaping the immune response. Immunology Research, 52(1–2), 111–119. [CrossRef] [PubMed] [Google Scholar]
  15. Ilić N, Kosanović M, Gruden-Movsesijan A, Glamočlija S, Sofronić-Milosavljević L, Čolić M, Tomić S. 2021. Harnessing immunomodulatory mechanisms of Trichinella spiralis to design novel nanomedical approaches for restoring self-tolerance in autoimmunity. Immunology Letters, 238, 57–67. [CrossRef] [PubMed] [Google Scholar]
  16. Iwahashi N, Yamamoto M, Nanjo S, Toujima S, Minami S, Ino K. 2017. Downregulation of indoleamine 2,3-dioxygenase expression in the villous stromal endothelial cells of placentas with preeclampsia, Journal of Reproductive Immunology 119, 54–60. [CrossRef] [PubMed] [Google Scholar]
  17. Jin X, Bai X, Yang Y, Ding J, Shi H, Fu B, Boireau P, Liu M, Liu X. 2020. NLRP3 played a role in Trichinella spiralis-triggered Th2 and regulatory T cells response. Veterinary Research, 51(1), 107. [CrossRef] [PubMed] [Google Scholar]
  18. Kobpornchai P, Flynn RJ, Reamtong O, Rittisoonthorn N, Kosoltanapiwat N, Boonnak K, Boonyuen U, Ampawong S, Jiratanh M, Tattiyapong M, Adisakwattana P. 2020. A novel cystatin derived from Trichinella spiralis suppresses macrophage-mediated inflammatory responses. PLoS Neglected Tropical Diseases, 14(4), e0008192. [CrossRef] [PubMed] [Google Scholar]
  19. Li C, Liu T, Zhao N, Zhu L, Wang P, Dai X. 2016. Dendritic cells transfected with indoleamine 2,3-dioxygenase gene suppressed acute rejection of cardiac allograft. International Immunopharmacology 36, 31–38. [CrossRef] [PubMed] [Google Scholar]
  20. Lippens C, Duraes FV, Dubrot J, Brighouse D, Lacroix M, Irla M, Aubry-Lachainaye JP, Reith W, Mandl JN, Hugues S. 2016. IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity. Journal of Autoimmunity, 75, 39–49. [CrossRef] [PubMed] [Google Scholar]
  21. Luo B, Que Z-J, Zhou Z-Y, Wang Q, Dong C-S, Jiang Y, Hu B, Shi H, Jin Y, Liu J-W, Li H-G, Wang L, Tian J-H. 2018. Feiji recipe inhibits the growth of lung cancer by modulating T-cell immunity through indoleamine-2, 3-dioxygenase pathway in an orthotopic implantation model. Journal of Integrative Medicine, 16(4), 283–289. [CrossRef] [PubMed] [Google Scholar]
  22. MacDonald AS, Maizels RM. 2008. Alarming dendritic cells for Th2 induction. Journal of Experimental Medicine, 205(1), 13–17. [CrossRef] [PubMed] [Google Scholar]
  23. Mancuso R, Hernis A, Agostini S, Rovaris M, Caputo D, Fuchs D, Clerici M. 2015. Indoleamine 2,3 Dioxygenase (IDO) expression and activity in relapsing-remitting multiple sclerosis. PLoS One, 10(6), e0130715. [CrossRef] [PubMed] [Google Scholar]
  24. Marian I, Ionică AM, Deak G, Ursache T, Lefkaditis M, Gherman CM, Mihalca AD. 2020. The effect of Trichinella spiralis on muscular activity of experimentally infected mice. Parasitology International, 76, 102032. [CrossRef] [PubMed] [Google Scholar]
  25. Meibers HE, Warrick KA, VonHandorf A, Vallez CN, Kawarizadeh K, Saha I, Donmez O, Jain VG, Kottyan LC, Weirauch MT, Pasare C. 2023. Effector memory T cells induce innate inflammation by triggering DNA damage and a non-canonical STING pathway in dendritic cells. Cell Reports, 42(10), 113180. [CrossRef] [PubMed] [Google Scholar]
  26. Moravej A, Kouhpayeh A, Geramizadeh B, Azarpira N, Yaghobi R, Mansoori Y, Karimi M-H. 2019. The effect of mesenchymal stem cells on the expression of IDOand Qa2 molecules in dendritic cells. Advanced Pharmaceutical Bulletin 9(1), 56–63. [CrossRef] [PubMed] [Google Scholar]
  27. Munn David H, Mellor Andrew L. 2016. IDO in the tumor microenvironment: Inflammation, counter-regulation, and tolerance. Trends in Immunology, 37(3), 193–207. [CrossRef] [PubMed] [Google Scholar]
  28. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. Journal of Experimental Medicine, 189(9), 1363–1372. [CrossRef] [PubMed] [Google Scholar]
  29. Rajan D, Chinnadurai R, O’Keefe EL, Boyoglu-Barnum S, Todd SO, Hartert TV, Galipeau J, Anderson LJ. 2017. Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells. Virology, 512, 144–150. [CrossRef] [Google Scholar]
  30. Reis e Sousa C. 2006. Dendritic cells in a mature age. Nature Reviews Immunology, 6(6), 476–483. [CrossRef] [PubMed] [Google Scholar]
  31. Schöniger S, Gräfe H, Richter F, Schoon HA. 2018. Expression of indoleamine 2,3-dioxygenase 1 as transcript and protein in the healthy and diseased equine endometrium. Research in Veterinary Science, 118, 278–287. [CrossRef] [PubMed] [Google Scholar]
  32. Sioud M, Nyakas M, Sæbøe-Larssen S, Mobergslien A, Aamdal S, Kvalheim G. 2016. Diversification of antitumour immunity in a patient with metastatic melanoma treated with ipilimumab and an IDO-silenced dendritic cell vaccine. Case Reports in Medicine, 2016, 9639585. [CrossRef] [Google Scholar]
  33. Sofronic-Milosavljevic L, Ilic N, Pinelli E, Gruden-Movsesijan A. 2015. Secretory Products of Trichinella spiralis muscle larvae and immunomodulation: Implication for autoimmune diseases, allergies, and malignancies. Journal of Immunology Research, 2015, 1–14. [CrossRef] [Google Scholar]
  34. Soliman H, Rawal B, Fulp J, Lee J-H, Lopez A, Bui MM, Khalil F, Antonia S, Yfantis HG, Lee DH, Dorsey TH, Ambs S. 2013. Analysis of indoleamine 2–3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunology, Immunotherapy, 62(5), 829–837. [CrossRef] [PubMed] [Google Scholar]
  35. Song YY, Zhang Y, Yang D, Ren HN, Sun GG, Jiang P, Liu RD, Zhang X, Cui J, Wang ZQ. 2018. The immune protection induced by a serine protease inhibitor from the foodborne parasite Trichinella spiralis. Frontiers in Microbiology, 9, 1544. [CrossRef] [PubMed] [Google Scholar]
  36. Takamatsu M, Hirata A, Ohtaki H, Hoshi M, Ando T, Ito H, Hatano Y, Tomita H, Kuno T, Saito K, Seishima M, Hara A. 2015. Inhibition of indoleamine 2,3‐dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice. Cancer Science, 106(8), 1008–1015. [CrossRef] [PubMed] [Google Scholar]
  37. Terness P, Chuang JJ, Opelz G. 2006. The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends in Immunology, 27(2), 68–73. [CrossRef] [PubMed] [Google Scholar]
  38. Wang XF, Wang HS, Wang H, Zhang F, Wang KF, Guo Q, Zhang G, Cai SH, Du J. 2014. The role of indoleamine 2, 3-dioxygenase (IDO) in immune tolerance: focus on macrophage polarization of THP-1 cells. Cellular Immunology, 289, 42–48. [CrossRef] [PubMed] [Google Scholar]
  39. Wobser M, Voigt H, Houben R, Eggert AO, Freiwald M, Kaemmerer U, Kaempgen E, Schrama D, Becker JC. 2007. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression. Cancer Immunology, Immunotherapy, 56(7), 1017–1024. [CrossRef] [PubMed] [Google Scholar]
  40. Wu Z, Sofronic-Milosavljevic L, Nagano I, Takahashi Y. 2008. Trichinella spiralis: nurse cell formation with emphasis on analogy to muscle cell repair. Parasites & Vectors, 1(1), 27. [CrossRef] [PubMed] [Google Scholar]
  41. Xie FT, Cao JS, Zhao J, Yu Y, Qi F, Dai XC. 2015. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3 + regulatory T cells. Transplant Immunology, 33(2), 69–77. [CrossRef] [PubMed] [Google Scholar]
  42. Xu D, Tang B, Wang Y, Zhang L, Qu Z, Shi W, Wang X, Sun Q, Sun S, Liu M. 2020. The immune protection induced by a serine protease from the Trichinella spiralis adult administered as DNA and protein vaccine. Acta Tropica, 211, 105622. [CrossRef] [PubMed] [Google Scholar]
  43. Xu SQ, Wang CY, Zhu XJ, Dong XY, Shi Y, Peng J, Qin P, Sun JZ, Guo C, Ni H, Hou M. 2012. Decreased indoleamine 2, 3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia. Annals of Hematology, 91(10), 1623–1631. [CrossRef] [PubMed] [Google Scholar]
  44. Yang Y, Cai YN, Tong MW, Sun N, Xuan YH, Kang YJ, Vallée I, Boireau P, Cheng SP, Liu MY. 2016. Serological tools for detection of Trichinella infection in animals and humans. One Health, 2, 25–30. [CrossRef] [PubMed] [Google Scholar]
  45. Yu YR, Deng MJ, Lu WW, Jia MZ, Wu W, Qi YF. 2013. Systemic cytokine profiles and splenic toll-like receptor expression during Trichinella spiralis infection. Experimental Parasitology, 134(1), 92–101. [CrossRef] [PubMed] [Google Scholar]
  46. Zhai L, Bell A, Ladomersky E, Lauing KL, Bollu L, Sosman JA, Zhang B, Wu JD, Miller SD, Meeks JJ, Lukas RV, Wyatt E, Doglio L, Schiltz GE, McCusker RH, Wainwright DA. 2020. Immunosuppressive IDO in cancer: mechanisms of action, animal models, and targeting strategies. Frontiers in Immunology, 11, 1185. [CrossRef] [PubMed] [Google Scholar]
  47. Zhang Y, Fu J, Shi Y, Peng S, Cai Y, Zhan X, Song N, Liu Y, Wang Z, Yu Y, Wang Y, Shi Q, Fu Y, Yuan K, Zhou N, Joshi R, Ichim TE, Min W. 2018. A new cancer immunotherapy via simultaneous DC-mobilization and DC-targeted IDO gene silencing using an immune-stimulatory nanosystem. International Journal of Cancer, 143(8), 2039–2052. [CrossRef] [PubMed] [Google Scholar]
  48. Zhang Y, Wang Y, Wu G, Zhang W, Wang X, Cai W, Zhang J, Han S, Li Y, Bai X, Shi J, Su L, Hu D. 2018. Prolonged skin grafts survival time by IFN-γ in allogeneic skin transplantation model during acute rejection through IFN-γ/STAT3/IDO pathway in epidermal layer. Biochemical and Biophysical Research Communications, 496(2), 436–442. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.